It has been reported that PPARδ can improve hepatic steatosis by activating fatty acid β-oxidation in different diet-induced models of steatohepatitis (NASH, obesity and insulin resistance)39–41. This evidence concerns the gene PPARD and metabolic dysfunction-associated steatohepatitis.